Article
02 Nov 2021
Federal Court Of Appeal Provides Guidance On Disclosure Exemptions In ATI Requests
AUTHORS CONTENT
Article
11 Oct 2021
Canada Seeks Leave To Appeal To The Supreme Court In PMPRB Excessive-pricing Case
Article
12 Aug 2021
Health Canada Reports On A National Strategy For Rare Disease Drugs
Article
27 Jul 2021
PMPRB Guidelines Update: Consultation On Changes Re Delayed Implementation
Article
09 Jul 2021
PMPRB Update: Delayed Implementation Of Patented Medicines Regulations Amendments And New Guidelines
Article
28 Jun 2021
CSP Amendments To The PMPRB Regime: Jurisdiction Of Patented Medicine Prices Review Board To Include Medicines Protected By Certificates Of Supplementary Protection
Article
14 Jun 2021
Federal Court Quashes NOC In Dispute Over Data Protection Provisions
Article
22 Apr 2021
New Periods For Compliance With The New Guidelines
Article
25 Mar 2021
Federal Court Of Appeal Provides Guidance On The "Inventive Concept"
Article
04 Mar 2021
Bill C-213, An Act To Enact The Canada Pharmacare Act: Rejected By Parliament
Article
05 Feb 2021
Federal Court Upholds Patent Validity And Issues Declarations Of Infringement Against Two Generic Apixaban Tablets
Article
03 Feb 2021
PM(NOC) Regulations Do Not Preclude Defendants From Amending The Statement Of Defence
Article
25 Jan 2021
Pharma In Brief: The 2020 Year In Review
Article
18 Jan 2021
Divided Success In PM(NOC) Actions Regarding Glatiramer Acetate
Article
13 Jan 2021
Prosecution History Cannot Be Invoked Against Patent Licensees
Article
18 Nov 2020
NOC Issued After Federal Court Overturns Minister's Decision On Effective Date Of Consent Letter Under The PM(NOC) Regulations
Article
02 Nov 2020
Federal Court Issues New Consolidated Guidelines On Complex Proceedings
Article
27 Oct 2020
PMPRB Update: Final Guidelines Released
Article
11 Sep 2020
Federal Courts Update Guidance On COVID-19
Article
09 Jul 2020
PMPRB Takes Jurisdiction Over Medicine (again) Following Federal Court Of Appeal Remand